Medical Care Technologies' Infinite Auctions is Set to Reach for the Record Books with High End Memorabilia Sales.

The ‘Make America Healthy Again' initiative challenges pharmaceutical influence, promotes access to natural therapies, and proposes regulatory changes to FDA oversight, food safety, and vaccine review protocols.

Reverse Split Becomes Effective Friday, June 27, 2025

Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements

This report explores how DentaGuard's natural formulation-featuring clinically studied probiotics and plant-based compounds-supports microbiome balance, gum comfort, breath freshness, and daily oral care habits without relying on invasive procedures or synthetic additives.

Company's CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing

Former PointClickCare and Current MacroHealth Chief Product Officer Deepens Company's Focus on Clinical Workflow Automation

Featured in MMR Magazine and Named a Top 100 Cosmetics Trend by TRENDHUNTER™

Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025

AI Nose and SLM SmellTech platform enter scale-up phase targeting robotics, automation, and environmental sensing markets

Kenmec and Ainos to show case AI Nose and SLM in Automation Taipei 2025 in August

~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~

~ Grant Funds from NIDA Accelerating Clinical Development Program ~

RevSpring, CarePayment, and Knowtion Health Recognized for Excellence in Patient Financial Technologies in Rankings Announced Today at HFMA ANI Conference

Rankings unveiled at HFMA Annual National Institute in Denver spotlight leading software solutions for Clearinghouse, Denial Management, and Claim Adjudication across hospitals and physician organizations

Comprehensive Rankings Highlight Leading Solutions Across Inpatient and Ambulatory Care Settings Based on Independent Client Satisfaction

Healthcare Finance Leaders Identify Top Software Solutions Across U.S. Hospital Segments Based on Real-World Results, ROI, and Financial Outcomes

As the HFMA ANI 2025 Meeting Kicks Off, New State Legislation Threatens to Reshape Revenue Cycle Management Disruption and Compliance Demands

Concierge Care Advisors Appoints Mary Cordova as Chief Concierge Officer and Promotes Shane Bray to Executive Vice President of Corporate Development

Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25%

Term loan maturity extended by 12 months to June 2029

Principal balance on term loan expanded to $13.0 million from $11.1 million currently

Expanded revolving line of credit facility by $1.5 million

Expanded facilities allow for added working capital flexibility as commercial launch of EXXUA is anticipated to occur in the fourth calendar quarter of 2025

Featuring lutein, zeaxanthin, alpha-lipoic acid, and quercetin, Vision Hero offers multi-pathway nutritional support for macular health, digital eye strain, and age-related visual changes.

Herbal liquid formula with mullein, eucalyptus, and cordyceps supports mucus clearance, deeper breathing, and restful sleep as part of a proactive approach to modern respiratory wellness in 2025.

Clinically dosed with standardized bergamot and hydroxytyrosol, the new Lipidene supplement offers a natural approach to lipid health and heart support aligned with 2025 wellness trends.

New report analyzes the clean nootropic formulation behind Vyvamind, detailing how each scientifically-backed ingredient supports mental clarity, focus, and sustainable cognitive performance in 2025.

A culture change is affecting how people talk about cosmetic surgery, from popular TikToks to BBL reversals. Dr. Meegan Gruber shows why choices made with knowledge and power are becoming more critical.

The FDA-cleared BloodVitals device leverages advanced optical sensor technology to deliver instant blood sugar, pulse, and oxygen readings-without skin penetration, test strips, or daily discomfort.

Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumors

New candidate APVO455 targets Nectin-4+ cancers, joins mipletamig (AML) and APVO442 (prostate) in Aptevo's tumor-directed CD3 suite

Formulated with antioxidant-rich nutrients and nano-delivery technology, LuminEye aims to support visual clarity, eye hydration, and night vision comfort without synthetic additives.

This collaboration underscores CliniOps' continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies.

With the launch of a new initiative, The Longevity Center is providing veterans with immediate access to discounted SGB therapy for PTSD and other trauma-related conditions

Formulated with lutein, zeaxanthin, bilberry, and saffron, the plant-based iGenics supplement delivers targeted nutritional support for digital eye strain, blue light exposure, and long-term macular wellness.